MME and diffuse large B-cell lymphoma: Using the Hans algorithm, we found a higher prevalence of non-GCB compared with GCB, aligning with previous reports that show non-GCB subtypes in 60%-72% of DLBCL patients.23-25 GCB subtypes are less common in Asia than in Western countries, possibly because of genetic polymorphisms or differences in diagnostic practices.23,26 This is particularly evident as the subtypes of 34.8% of patients with DLBCL in this study could not be classified because of incomplete result of CD10, BCL6, and MUM1 markers.